Rondol

Interview at SantExpo 2024 – Christophe Eychenne-Baron and Victoire de Margerie on relocalization of drug production to France

The pandemic exposed the overreliance on foreign suppliers for critical medical products. In this interview at SantExpo 2024, Christophe Eychenne-Baron of SEQENS Pharmaceutical Solutions and Victoire de Margerie of Rondol Group discuss the challenges and opportunities of localizing production of medicines in France and their collaboration together to improve the bioavailability of drugs while decreasing costs and environmental footprint.

You can find an English transcription of the interview here: SantExpo 2024 Interview Transcription (PDF).